
|Articles|March 1, 1997
Supplements and Featured Publications
- Integrating Risk Factor Management of Coronary Heart Disease into Managed Care
- Volume 3
- Issue 3 Suppl
Safety and Tolerability of Lipid-Lowering Drugs After Heart Transplantation: The Heart Transplant Lipid Registry
Author(s)Christie M. Ballantyne, MD
Advertisement
Articles in this issue
over 28 years ago
Goals and Objectivesover 28 years ago
Introductionover 28 years ago
Risk-Factor Management in Women and Other Special Patientsover 28 years ago
Risk Factor Management: Exploring the Boundariesover 28 years ago
CME Quizover 28 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Clinician Shortages, Access Gaps Challenge Rural Primary Care
3
Guselkumab Shows Sustained 48-Week Protection Against Joint Damage in PsA
4
Diet, Lifestyle Come Into Focus for Managing Multiple Sclerosis: Rebecca Spain, MD
5















































